NCT01800435View on ClinicalTrials.gov

A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With Inhibitor

PHASE4CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
Hereditary Factor VIII Deficiency Disease With Inhibitor
Interventions
DRUG

aPCC, aPCC + TXA

Feiba 75 IU/kg i.v Feiba 75 IU/kg i.v +Cyklokapron 20 mg/kg p.o

DRUG

rFVIIa, rFVIIa + TXA

NovoSeven 90 µg/kg i.v NovoSeven 90 µg/kg i.v + Cyklokapron 20 mg/kg

Trial Locations (1)

0424

Oslo University Hospital, Oslo

All Listed Sponsors
lead

Oslo University Hospital

OTHER

NCT01800435 - A Comparison Study of Bypassing Agent Therapy With and Without Tranexamic Acid in Haemophilia A Patients With Inhibitor | Biotech Hunter | Biotech Hunter